Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Infection

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

Arboviral Encephalitis

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...

Viral Meningitis

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

JAMA neurology·2026

Same author

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Neurology(R) neuroimmunology & neuroinflammation·2026

Same author

CSF1R inhibition following antibody mediated demyelination has limited impact on remyelination.

Acta neuropathologica communications·2026

Same author

Intrinsic endothelial remodeling drives brain capillary repair.

Neuron·2026

Same author

Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis.

Clinical neurology and neurosurgery·2026

Same author

Extensive peripheral immunoglobulin repertoire analyses in people with multiple sclerosis reveal disease-specific signatures and distinct treatment effects of disease modifying drugs.

Journal of neuroinflammation·2026

Search research articles

Related Experiment Video

Updated: May 21, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.

Gregory P Owens¹, Jeffrey L Bennett

¹Department of Neurology, University of Colorado Denver, Aurora, CO 80045, USA. greg.owens@ucdenver.edu

Multiple Sclerosis (Houndmills, Basingstoke, England)

|June 12, 2012

Summary

The Epstein-Barr Virus (EBV) is a leading hypothesis for multiple sclerosis (MS) pathogenesis, potentially triggering autoimmune responses in susceptible individuals. This review examines EBV

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Related Experiment Videos

Last Updated: May 21, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Area of Science:

Neuroimmunology
Virology
Epidemiology

Background:

Multiple Sclerosis (MS) pathophysiology has long been debated regarding a potential viral cause, with epidemiological studies suggesting environmental factors.
Despite extensive research, no virus has been definitively linked to MS lesion formation or identified as the causative agent.
Oligoclonal IgG bands, typical in CNS infections, are inconsistently found in MS, complicating the search for a specific pathogen.

Purpose of the Study:

To review the epidemiological evidence linking Epstein-Barr Virus (EBV) to Multiple Sclerosis (MS).
To discuss the immunological response to EBV in MS patients.
To evaluate the necessity of EBV brain infection in the development of MS pathology.

Main Methods:

Review of epidemiological studies on MS and viral infections.
Analysis of immunological data concerning EBV in MS patients.
Discussion of existing hypotheses on MS pathogenesis involving infectious agents.

Main Results:

No virus has been unequivocally associated with MS lesion formation.
Epstein-Barr Virus (EBV), a common human herpes virus, is a leading candidate for triggering MS in genetically susceptible individuals.
EBV's role is hypothesized as an environmental trigger initiating autoimmune responses rather than a direct causative agent.

Conclusions:

The hypothesis that common infectious agents, particularly EBV, can initiate autoimmune responses in genetically susceptible individuals is a prominent theory for MS pathogenesis.
Further research is needed to clarify the precise role of EBV epidemiology and immunology in MS.
The necessity of EBV brain infection for MS pathology remains an open question.